ONLY LIMITED SPOTS
By submitting this form you subscribe to our mailing list and agree to the privacy policy.
Unexpected Diagnoses based on Whole Genome Sequencing
May 25, 2022 - 2PM CET (KSA: 3PM – UAE: 4PM)
It is estimated that 80% of rare diseases are genetic, making Whole Genome Sequencing (WGS) the most promising technology for the early diagnosis and management of rare diseases.
Rare diseases, defined as diseases affecting less than 1 in 2000 people in Europe, impacting a total of more than 400 million people worldwide. The number of rare diseases is estimated at around 7000, and most of them are usually chronically debilitating or even life-threatening.
During this Webinar, our Founder and CEO Prof. Dr. Arndt Rolfs, who is a German professor and one of the world's most renowned experts on genetic diseases with more than 30 years of experience and over 400 international scientific publications, will help you understand the following:
Arndt is a Professor at the University of Rostock, Germany. He is a multi-entrepreneur in biotech, founder, and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE.
He received his MD in 1985 and was granted a tenure track professorship for clinical neurology in 1997 at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt has initiated multiple international multicenter studies in genetic disorders with an extensive track record in medical and scientific publications.
Speaker
Prof. Dr. Arndt Rolfs,
CEO and Founder Arcensus GmbH
Arndt is a Professor at the University of Rostock, Germany. He is a multi-entrepreneur in biotech, founder, and former CEO of several innovative biotech companies, including Nasdaq-listed company CENTOGENE.
He received his MD in 1985 and was granted a tenure track professorship for clinical neurology in 1997 at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt has initiated multiple international multicenter studies in genetic disorders with an extensive track record in medical and scientific publications.
Speaker
Prof. Dr. Arndt Rolfs,
CEO and Founder Arcensus GmbH
Unexpected Diagnoses based on Whole Genome Sequencing
May 25, 2022 - 2PM CET
2022. All rights reserved by Arcensus GmbH
2022. All rights reserved by Arcensus GmbH
It is estimated that 80% of rare diseases are genetic, making Whole Genome Sequencing (WGS) the most promising technology for the early diagnosis and management of rare diseases.
Rare diseases, defined as diseases affecting less than 1 in 2000 people in Europe, impacting a total of more than 400 million people worldwide. The number of rare diseases is estimated at around 7000, and most of them are usually chronically debilitating or even life-threatening.
During this Webinar, our Founder and CEO Prof. Dr. Arndt Rolfs, who is a German professor and one of the world's most renowned experts on genetic diseases with more than 30 years of experience and over 400 international scientific publications, will help you understand the following:
Duration: 45 minutes
(KSA: 4PM – UAE: 5PM) - Duration: 45 minutes
In addition to that, Prof. Rolfs will present several clinical cases where the WGS has enabled patients to be diagnosed after a long diagnostic odyssey.
- How advances in WGS technology have ushered in a new era for molecular diagnosis and disease gene discovery?
- How the rarity and heterogeneity of phenotypes, can cause the conventional misclassification of cases and control in the clinical diagnosis of rare diseases?
- How to avoid misidentification of potentially causative variants?
- Why do local genomic reference data banks have to be structured separately for each ethnicity?
- How a definitive diagnosis can be made in 75-80% of all patients with the help of WGS at fewer costs?